XML 43 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock Option Plans (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options

Stock option activity for employees and non-employees under the Equity Compensation Plans for the six months ended June 30, 2024 was as follows:

 

Options

 

 

Weighted
Average
Exercise Price

 

 

Weighted Average Remaining Contractual Life (periods)

 

 

Aggregate Intrinsic Value

 

Outstanding options, December 31, 2023

 

 

1,009,519

 

 

$

15.01

 

 

 

6.19

 

 

$

664,967

 

Granted

 

 

1,104,000

 

 

$

5.13

 

 

 

 

 

 

 

Forfeited

 

 

(204,767

)

 

$

6.60

 

 

 

 

 

 

 

Exercised

 

 

(3,780

)

 

$

5.40

 

 

 

 

 

 

 

Expired

 

 

(18,599

)

 

$

44.28

 

 

 

 

 

 

 

Outstanding options, June 30, 2024

 

 

1,886,373

 

 

$

9.92

 

 

 

7.63

 

 

 

 

Options vested and exercisable, June 30, 2024

 

 

618,836

 

 

$

18.12

 

 

 

4.05

 

 

 

 

Summary of Assumptions Used to Calculate Estimated Fair Value of Stock Options

The estimated fair value of stock options granted to employees and consultants during the three and six months ended June 30, 2024 and 2023, were calculated using the Black-Scholes option-pricing model using the following assumptions:

 

 

Three Months Ended June 30,

 

For The Six Months Ended June 30,

 

2024

 

2023

 

2024

 

2023

Expected volatility

 

90.4

 

%

 

80.2 - 81.5

 

%

 

89.9 - 90.4

 

%

 

80.2 - 81.9

 

%

Weighted-average volatility

 

 

90.4

 

%

 

 

80.9

%

%

 

 

89.9

 

%

 

 

81.7

%

%

Expected dividends

 

 

%

 

 

%

 

 

%

 

 

%

Expected term (in periods)

 

6.08

 

 

 

5.77 - 6.08

 

 

 

5.73 - 6.08

 

 

 

5.77 - 6.08

 

 

Risk-free rate

 

4.27

 

%

 

3.50 - 3.90

 

%

 

4.26 - 4.32

 

%

 

3.50 - 3.90

 

%

Summary of Restricted Stock

Stock award activity for employees and non-employees under the Equity Compensation Plans for the six months ended June 30, 2024 was as follows:

 

Number of shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested as of December 31, 2023

 

 

66,887

 

 

$

11.56

 

Vested

 

 

(27,160

)

 

$

11.20

 

Unvested as of June 30, 2024

 

 

39,727

 

 

$

10.59

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for the three and six months ended June 30, 2024 and 2023 was as follows:

 

 

Three Months Ended June 30,

 

 

For The Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

274,317

 

 

$

166,534

 

 

$

490,668

 

 

$

314,225

 

General and administrative

 

 

327,116

 

 

 

478,281

 

 

 

728,210

 

 

 

933,370

 

Total

 

$

601,433

 

 

$

644,815

 

 

$

1,218,878

 

 

$

1,247,595